NewEdge Wealth’s Boston Scientific BSX Stock Holding History

NewEdge Wealth’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.52M	Sell	56,101 -16,515	-23%	-$1.32M	0.04%	290
2025 Q4	$6.92M	Buy	72,616 +9,917	+16%	+$972K	0.08%	176
2025 Q3	$6.2M	Buy	62,699 +9,826	+19%	+$1.02M	0.09%	175
2025 Q2	$5.44M	Buy	52,873 +5,569	+12%	+$563K	0.09%	186
2025 Q1	$4.77M	Buy	47,304 +3,709	+9%	+$373K	0.09%	195
2024 Q4	$3.89M	Sell	43,595 -540	-1%	-$47.5K	0.07%	228
2024 Q3	$3.7M	Buy	44,135 +2,543	+6%	+$200K	0.07%	250
2024 Q2	$3.2M	Sell	41,592 -2,068	-5%	-$151K	0.07%	233
2024 Q1	$3.14M	Sell	43,660 -5,839	-12%	-$375K	0.07%	235
2023 Q4	$2.86M	Sell	49,499 -2,717	-5%	-$145K	0.07%	234
2023 Q3	$2.76M	Buy	52,216 +16,290	+45%	+$854K	0.09%	202
2023 Q2	$1.94M	Buy	35,926 +31,539	+719%	+$1.65M	0.06%	258
2023 Q1	$219K	Sell	4,387 -10,092	-70%	-$476K	0.01%	567
2022 Q4	$670K	Buy	14,479 +5,601	+63%	+$243K	0.03%	330
2022 Q3	$344K	Buy	+8,878	New	+$356K	0.02%	401

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NewEdge Wealth's BSX Position: Q1 2026 in Review

NewEdge Wealth reduced its Boston Scientific (BSX) stake by 23% in Q1 2026, selling an estimated $1.32M and leaving 56,101 shares worth $3.52M. The position accounts for 0.04% of the portfolio, ranked #290.

NewEdge Wealth first reported a position in BSX in Q3 2022 and has held it in 15 quarters since. The position peaked at $6.92M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

NewEdge Wealth held 56,101 shares of Boston Scientific worth $3.52M as of Q1 2026.
NewEdge Wealth sold 16,515 Boston Scientific shares in Q1 2026, an estimated $1.32M.
Boston Scientific made up 0.04% of NewEdge Wealth's portfolio in Q1 2026, its #290 holding.
NewEdge Wealth first reported a position in Boston Scientific in Q3 2022 and has held it in 15 quarters since.
NewEdge Wealth's Boston Scientific position peaked at $6.92M in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.